My latest Seeking Alpha article:
GlycoMimetics: Undercovered with Catalysts Coming
I originally bought GLYC on March 31, 2015, then on April 17. Then more on August 24, 2015. Mostly lately bought on January 13, 2016.
I want more, but I'd have to sell something first, and that would mean (most likely) selling one of my winners with solid profits. And as much as I like GlycoMimetics, it is a development stage company. If its VOC trial fails, that would mean a price plunge. So for now I'll just be patient.
Waiting for biotechnology drug pipelines to mature is a major test of patience.